Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management intype 2 diabetes

R.E. van Genugten, D.L. Moller-Goede, D.H. van Raalte, M. Diamant

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)593-606
JournalDiabetes, Obesity and Metabolism
Volume15
Issue number7
DOIs
Publication statusPublished - 2013

Cite this